Patents
Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692)
07/2012
07/24/2012US8227575 Cytokine zalpha11 ligand antibodies
07/24/2012US8227413 Compositions and methods for inducing angiogenesis
07/24/2012US8226976 Method of using cell-free protein synthesis to produce a membrane protein
07/24/2012CA2536182C Macrocyclic peptides active against the hepatitis c virus
07/24/2012CA2488167C Prodrugs of excitatory amino acids
07/19/2012WO2012097344A2 Metal abstraction peptide and uses thereof
07/19/2012WO2012096596A1 Antiviral agent
07/19/2012WO2012030217A3 Culture medium for eukaryotic cells
07/19/2012US20120183954 Luminescent dyes with a water-soluble intramolecular bridge and their biological conjugates
07/19/2012US20120183570 Antigen compositions and methods of inhibiting campylobacter jejuni bacterial infection and uses of the antigen compositions
07/19/2012US20120183554 Biomarker
07/19/2012CA2824151A1 Antigen surrogates in autoimmune disease
07/19/2012CA2814763A1 Compositions comprising enzyme-cleavable oxycodone prodrug
07/18/2012EP2476691A1 Method for manufacturing a lipidic peptide compound
07/18/2012CN102596986A Method for manufacturing a lipidic peptide compound
07/18/2012CN102584941A Paddy rice Ustiloxin A extracting and purifying method
07/18/2012CN102584940A Peptidic compounds
07/18/2012CN102584939A Peptidic compounds
07/18/2012CN102584938A Crystallizing method of aspartame
07/18/2012CN102584937A Crystal forms of (3r)-1-(2-methylalanyl-d-tryptophyl)-3-(phenylmethyl)-3-piperidinecarboxylic acid 1,2,2-trimethylhydrazide
07/18/2012CN101863958B Induction of the mitochondrial permeability transition
07/18/2012CN101440124B Methods for preventing mitochondrial permeability transition
07/18/2012CN101273030B Macrocyclic inhibitors of hepatitis C virus
07/17/2012US8222392 Kit for detection of telomerase reverse transcriptase nucleic acids
07/17/2012US8222201 Crystalline form of linaclotide
07/17/2012US8221969 Method of producing virus
07/17/2012CA2522561C Quinoxalinyl macrocyclic hepatitis c serine protease inhibitors
07/17/2012CA2277486C Synthetic antibiotics
07/12/2012US20120177780 Method for improving bread-making properties of rice flour bread dough
07/12/2012US20120177580 Metal Abstraction Peptide (MAP) Tag and Associated Methods
07/11/2012EP2473517A1 Transglutaminase-activating peptide, and cosmetic or pharmaceutical composition containing same
07/11/2012EP2473516A1 Antibiotic compounds
07/11/2012EP1300416B1 Memory-enhancing peptides and the use thereof
07/11/2012CN102574892A Antibiotic compounds
07/11/2012CN102558302A Method for separating and purifying pristinamycin
07/11/2012CN102558299A Synthetic polypeptide and application thereof
07/11/2012CN102558298A Method for synthesizing tetrapeptide isomers by using solid phase peptide synthesis method and applications of tetrapeptide isomers
07/11/2012CN102558297A Endomorphin-1 analogue modified by alpha-alkenyl-beta-amino acid and composition and application thereof
07/11/2012CN102558270A 20(S) and 20(R)-dammarane-3beta,12beta,20,25-tetrol derivative and preparation method and application thereof
07/11/2012CN102558165A Smac peptidomimetics useful as iap inhibitors
07/11/2012CN102557989A Ulimorelin intermediate and Ulimorelin preparation method
07/11/2012CN101282978B Macrocylic inhibitors of hepatitis c virus
07/11/2012CN101006097B Vla-4 antagonists
07/10/2012US8217158 Immunotoxin fusion proteins and means for expression thereof
07/10/2012US8217142 Liquid phase peptide synthesis of KL-4 pulmonary surfactant
07/10/2012US8217137 Fullerene-based amino acids
07/10/2012US8217048 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
07/10/2012CA2481369C Inhibitors of serine proteases, particularly hepatitis c virus ns3 - ns4 protease
07/10/2012CA2439101C New medical uses of intercellular communication facilitating compounds
07/05/2012US20120172422 Methods of Treatment Using a Prodrug of an Excitatory Amino Acid
07/05/2012US20120172291 Macrocyclic hepatitis c serine protease inhibitors
07/05/2012US20120172290 Anti-Viral Compounds
07/04/2012EP2471944A1 Novel peptidase substrates
07/04/2012EP2470216A1 Peptide clearing agents
07/04/2012EP2470189A1 Processes for preparing protease inhibitors of hepatitis c virus
07/04/2012EP2178888B1 Proteasome inhibitors
07/04/2012EP1472238B1 Bioluminescent protease assay
07/04/2012CN102533549A Nanogel scaffold material for culturing and desorbing type of cells and preparation method thereof
07/04/2012CN102532262A Preparation of fatty acid-RGD-fatty alcohol conjugate mediated epirubicin targeted liposome and evaluation on anticancer activity
07/04/2012CN102532261A Bone remodeling activator-typrotide and medicament composition and application thereof
07/04/2012CN102532260A Silkworm chrysalis protein source dipeptide DA and uses thereof
07/04/2012CN102532259A Oligopeptide-based cationic lipid derivative and application thereof in pharmaceutical preparation
07/04/2012CN102532198A Antiviral phosphinate compounds
07/04/2012CN102532051A 有丝分裂驱动蛋白抑制剂及其使用方法 Mitotic kinesin inhibitors and methods of use
07/04/2012CN102199111B Process and intermediates for the preparation of hepatitis C virus protease inhibitor
07/04/2012CN101967183B Artificially synthesized novel antithrombotic peptide derivative, preparation method and application thereof
07/04/2012CN101092455B Peptides and peptidomimetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments
06/2012
06/28/2012WO2012087888A2 Efficient peptide couplings and their use in the synthesis and isolation of a cyclopenta (g) quinazoline trisodium salt
06/28/2012WO2012085479A1 Process for preparing platinum-carbene complexes
06/28/2012WO2012085475A1 Novel platinum-carbene complexes and use thereof as medicaments
06/28/2012WO2012083436A1 Trypsin-like serine protease inhibitors, their preparation and use as selective inhibitors of the clotting factors iia and xa
06/28/2012WO2012083424A1 Novel amino acid linker sequences for ligand immobilization
06/28/2012WO2011135464A3 N-(aminoacyl)-amino compound
06/28/2012US20120165566 Processes for intermediates for macrocyclic compounds
06/28/2012US20120165296 Bisphosphonate-prodrugs
06/28/2012US20120165276 Quaternary alkyl ammonium bacterial efflux pump inhibitors and therapeutic uses thereof
06/28/2012US20120165260 Crystalline ezatiostat hydrochloride ansolvate
06/28/2012US20120165248 Glutathione Derivatives and Their Uses for the Treatment of Viral Diseases
06/28/2012US20120164230 Soluble Nanoparticles as Delivery Systems for Prodrugs
06/28/2012CA2822411A1 Process for preparing platinum-carbene complexes
06/28/2012CA2822410A1 Novel platinum-carbene complexes and use thereof as medicaments
06/28/2012CA2822350A1 Trypsin-like serine protease inhibitors, their preparation and use as selective inhibitors of the clotting factors iia and xa
06/28/2012CA2819510A1 Efficient peptide couplings and their use in the synthesis and isolation of a cyclopenta(g)quinazoline trisodium salt
06/27/2012EP2468744A2 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
06/27/2012CN102516355A Peptide derivative of benzfuran quinoline and preparation method thereof and application thereof as antitumor medicament
06/27/2012CN101906097B 1,3-dioxane compounds as well as synthesizing method and medical application thereof
06/27/2012CN101497651B Compound with thrombus dissolving activity, as well as preparation and use thereof
06/26/2012US8207299 Citrulline peptides derived from fibrin and recognized by rheumatoid arthritis specific autoantibodies, and the use thereof
06/26/2012US8207297 Compounds for enzyme inhibition
06/26/2012US8207131 Peptide
06/26/2012US8207128 Polypeptide inhibiting transmigration of leukocytes or growth and/or metastasis of cancer cells, and fusion protein thereof
06/26/2012US8207127 Compounds for enzyme inhibition
06/26/2012US8207126 Compounds for enzyme inhibition
06/26/2012US8207125 Compounds for enzyme inhibition
06/26/2012US8207124 Compounds for enzyme inhibition
06/26/2012CA2445875C Pentapeptide compounds and uses related thereto
06/26/2012CA2270448C Method for giving resistance to weed control compounds to plants
06/26/2012CA2237316C Complex cationic lipids
06/26/2012CA2220021C Biologically active peptides and compositions, their use
06/21/2012WO2012061408A3 Method for making macrocycles
1 ... 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 ... 307